ARTICLE | Company News
Ixsys deal
July 5, 1994 7:00 AM UTC
The San Diego company received an exclusive license from the Scripps Research Institute for a monoclonal antibody to treat malignant tumors (see BioCentury April 25, 1994 for in vitro data). Ixsys wil...